Literature DB >> 568534

Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them.

G E Poley, C A Shively, E S Vesell.   

Abstract

After a single oral dose of aminopyrine (9 mg/kg), mean salivary aminopyrine half-lives (t 1/2s) and metabolic clearance rates in 12 normal male volunteers exhibited diurnal variations. Salivary aminopyrine t 1/2s were approximately 50% longer at 8 P.M. (2.1 +/- 0.7 hr) than at 8 A.M. (1.4 +/- 0.3 hr). Mean aminopyrine metabolic clearance rates decreased 20% from 8 A.M. (418.2 +/- 152.0 ml/min) to 8 P.M. (335.3 +/- 107.6 ml/min). There were large interindividual variations in the magnitude of these diurnal changes in aminopyrine t 1/2 and metabolic clearance rates. There were nonsignificant changes in mean aminopyrine apparent volumes of distribution (aVd) which increased only slightly from 53.1 +/- 20.6 L at 8 A.M. to 59.7 +/- 26.5 L at 8 P.M. There were diurnal variations in plasma 11-hydroxycorticosteroids (11-OHCS), mean values of which decreased 60% from 16.2 +/- 4.2 microgram/100 ml at 8 A.M. to 6.5 +/- 1.9 microgram/100 ml at 8 P.M. Sleeplessness for 24 or 48 hr under the conditions of this experiment failed to affect diurnal rhythms in aminopyrine metabolism or plasma 11-OHCS concentrations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568534     DOI: 10.1002/cpt1978246726

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

1.  Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.

Authors:  W A McAllister; D M Mitchell; J V Collins
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

2.  Influence of pharmacokinetic diurnal variation on bioavailability estimates.

Authors:  L A Bauer; M Gibaldi; R E Vestal
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

3.  Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit. II. Multiple dose study.

Authors:  T Ishizaki; Y Horai; T Sasaki; K Chiba; A Ohnishi; T Suganuma; G Tsujimoto; H Echizen; T Okaniwa
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Pharmacokinetics of theophylline in night-workers.

Authors:  S Decourt; F Fodor; B Flouvat; A Pradalier; J Dry
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.